imatinib-oral Related Diseases & Conditions

Medications are used to manage a variety of conditions. Our doctors have compiled a list of ailments that the medication imatinib-oral may be used to treat or manage.

  • Leukemia Leukemia is a type of cancer of the blood cells in which the growth and development of the blood cells are abnormal. Strictly...learn more »
    In This Article
    Leukemia Article
    • Leukemia facts
    • What is leukemia? What are the different types of leukemia?
    • What causes leukemia? Is leukemia hereditary?
    • What are leukemia risk factors?
    • What are leukemia symptoms and signs?
    • How do physicians diagnose leukemia?
    • What is the treatment for leukemia?
    • What are complications of leukemia?
    • What is the prognosis of leukemia?
    • Is it possible to prevent leukemia?
    • What support groups are available for people with leukemia?
    • What research is being done on leukemia?
  • Childhood Acute Lymphoblastic Leukemia (ALL) Childhood acute lymphoblastic leukemia is the most common type of cancer in children. Symptoms and signs include fever, easy...learn more »
    In This Article
    Childhood Acute Lymphoblastic Leukemia (ALL) Article
    • Childhood acute lymphoblastic leukemia (ALL) is a type of cancer in which the bone marrow makes too many immature lymphocytes (a type of white blood cell).
    • Family history and exposure to radiation may affect the risk of developing childhood ALL.
    • Possible signs of childhood ALL include fever and bruising.
    • Tests that examine the blood and bone marrow are used to detect (find) and diagnose childhood ALL.
    • Certain factors affect prognosis (chance of recovery) and treatment options.
    • In childhood ALL, risk groups are used instead of stages.
    • What is recurrent childhood acute lymphoblastic leukemia (ALL)?
    • There are different types of treatment for childhood acute lymphoblastic leukemia (ALL).
    • New types of treatment are being tested in clinical trials.
    • What is the treatment for recurrent childhood acute lymphoblastic leukemia (ALL)?